Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Frederick M. Kuenzi is active.

Publication


Featured researches published by Frederick M. Kuenzi.


Neuroscience Letters | 2000

Similar levels of long-term potentiation in amyloid precursor protein -null and wild-type mice in the CA1 region of picrotoxin treated slices

Stephen M. Fitzjohn; Robin A. Morton; Frederick M. Kuenzi; Ceri H. Davies; Guy R. Seabrook; Graham L. Collingridge

Although mutations in amyloid precursor protein (APP) are known to be involved in the development of Alzheimers disease in some individuals, the role of this protein in normal brain function is poorly understood. We have reported previously that in APP-null mice long-term potentiation (LTP) in the CA1 region of the hippocampus is present but its magnitude is reduced compared to wild-type littermate controls. In the present study, we have confirmed this deficit using a different theta burst induction protocol. Significantly, however, we find that this deficit is no longer apparent when LTP experiments are performed following blockade of gamma-aminobutyric acid(A) receptors. These results suggest that the LTP process per se is not altered by the absence of APP. The deficit may therefore be an indirect consequence of other changes in the hippocampus that occur in the APP-null animal.


Journal of Neuroscience Methods | 2000

Reduced long-term potentiation in hippocampal slices prepared using sucrose-based artificial cerebrospinal fluid.

Frederick M. Kuenzi; Stephen M. Fitzjohn; Robin A. Morton; Graham L. Collingridge; Guy R. Seabrook

Sucrose-based artificial cerebrospinal fluid (aCSF) is sometimes used to prepare brain slices for in vitro electrophysiological experiments. This study compared the effect of preparing brain slices using chilled sucrose-based aCSF versus the conventional method using chilled aCSF on hippocampal synaptic plasticity. Brain slices from each treatment group were transferred to normal aCSF before electrophysiological recordings were made. The stimulus-response relationship of field excitatory postsynaptic potentials (fEPSPs) in the CA1 region was indistinguishable between the two treatment groups. However, the amount of LTP induced by either a θ-burst (four stimuli at 100 Hz repeated ten times at 200 ms intervals) or tetanic stimulation (100 Hz for 1 s) was significantly reduced in slices that had been prepared using sucrose-based aCSF. This was associated with reduced facilitation of the fEPSPs during the high frequency stimulus, reduced post-tetanic potentiation and short-term potentiation. In sucrose-cut slices the fEPSPs were slightly shorter in duration (29%, P<0.01), and during paired-pulse stimulation the broadening of the second fEPSP was enhanced. The LTP deficit in sucrose-cut slices was reversed by blocking GABA(A) receptor function with picrotoxin. These data suggest that the use of sucrose based aCSF better preserves GABA-mediated synaptic transmission, which limits the induction of LTP in hippocampal brain slices.


Neuroscience Letters | 2002

Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1

Robin A. Morton; Frederick M. Kuenzi; Stephen M. Fitzjohn; Thomas W. Rosahl; David W Smith; Hui Zheng; Mark S. Shearman; Graham L. Collingridge; Guy R. Seabrook

Presenilin-1 (PS1) is intimately involved in cleavage of amyloid precursor protein to form beta-amyloid peptides, certain forms of which aggregate in the brains of patients with Alzheimers disease (AD). The function(s) of PS1 and its precise involvement in the development of cognitive deficits associated with AD are unclear. We have utilised genetically modified mice that under-express PS1 (PS1(+/-) mice) to investigate the role of PS1 in hippocampal synaptic plasticity. Field excitatory postsynaptic responses elicited by baseline stimulation were indistinguishable between PS1(+/-) mice and wild-type controls. Likewise, a measure of short-term plasticity, paired-pulse facilitation, was normal in PS1(+/-) mice. However, long-term potentiation induced by multiple tetanus trains was reduced in PS1(+/-) animals. These results demonstrate that chronic reduction of PS1 activity leads to impaired synaptic plasticity, thus suggesting a role for PS1 in normal cognitive function.


Brain Research | 2003

Hippocampal synaptic plasticity in mice carrying the rd mutation in the gene encoding cGMP phosphodiesterase type 6 (PDE6)

Frederick M. Kuenzi; Thomas W. Rosahl; Robin A. Morton; Stephen M. Fitzjohn; Graham L. Collingridge; Guy R. Seabrook

Cyclic GMP (cGMP) has been implicated in the modulation of long-term potentiation (LTP) and depression (LTD) in the hippocampus. Transcripts for subunits of several types of cGMP specific phosphodiesterase are found in the mammalian brain but their relative role in hippocampal function is unclear. The retinal degeneration (rd) mutation in the gene encoding the PDE6B subunit causes a loss of function in PDE6 enzyme and in adult mice homozygous to the mutation it causes blindness. We have used this natural mutation, and the cGMP phosphodiesterase inhibitor zaprinast, in wild-type and rd/rd mouse littermates to investigate whether PDE5 and/or PDE6 regulates excitatory synaptic transmission in the hippocampus. Mice were genotyped using two independent PCR methods. Glutamate-mediated synaptic transmission in the CA1 region or dentate gyrus was unaffected in hippocampal brain slices from mice carrying the rd mutation. Similarly the facilitation of synaptic events by paired-pulse stimuli, and LTP induced by a theta-burst (10 bursts of four events at 100 Hz with a 200-ms inter-burst interval) were normal in rd/rd mice. Inhibition of cGMP-specific PDE activity by zaprinast (10 microM, an inhibitor of PDE5 and PDE6) induced a slowly developing and sustained depression of field synaptic potentials that was quantitatively similar in both wild-type and rd/rd mice. Thus in the CA1 region synaptic plasticity is likely to be regulated by the PDE5 rather than the PDE6 isoform.


Molecular Brain | 2010

A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1

Stephen M. Fitzjohn; Frederick M. Kuenzi; Robin A. Morton; Tomas W. Rosahl; Huw D. Lewis; David W Smith; Guy R. Seabrook; Graham L. Collingridge

Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal slices have been studied during ageing of a double transgenic mouse strain relevant to early-onset familial Alzheimers disease (AD). This strain, which over-expresses both the 695 amino acid isoform of human amyloid precursor protein (APP) with K670N and M671L mutations and presenilin 1 with the A246E mutation, has accelerated amyloidosis and plaque formation. There was a decrease in synaptic transmission in both wildtype and transgenic mice between 2 and 9 months of age. However, preparing slices from 14 month old animals in kynurenic acid (1 mM) counteracted this age-related deficit. Basal transmission and paired-pulse facilitation was similar between the two groups at all ages (2, 6, 9 and 14 months) tested. Similarly, at all ages LTP, induced either by theta burst stimulation or by multiple tetani, was normal. These data show that a prolonged, substantially elevated level of Aβ are not sufficient to cause deficits in the induction or expression of LTP in the CA1 hippocampal region.


The Journal of Neuroscience | 2002

Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor

Neil Collinson; Frederick M. Kuenzi; Wolfgang Jarolimek; Karen A. Maubach; Rosa Cothliff; Cyrille Sur; Alison J. Smith; Franklin Otu; Owain W. Howell; John R. Atack; Ruth M. McKernan; Guy R. Seabrook; G. R. Dawson; Paul J. Whiting; Thomas W. Rosahl


The Journal of Neuroscience | 2001

Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein

Stephen M. Fitzjohn; Robin A. Morton; Frederick M. Kuenzi; Thomas W. Rosahl; Mark S. Shearman; Huw D. Lewis; David W Smith; David S. Reynolds; Ceri H. Davies; Graham L. Collingridge; Guy R. Seabrook


The Journal of Neuroscience | 1998

The Pharmacology and Roles of two K+ Channels in Motor Pattern Generation in the Xenopus Embryo

Frederick M. Kuenzi; Nicholas Dale


Journal of Neuroscience Methods | 2004

Design and application of a novel brain slice system that permits independent electrophysiological recordings from multiple slices

M. Stopps; Nicholas Denby Allen; R. Barrett; Hedaythul I. Choudhury; W. Jarolimek; M. Johnson; Frederick M. Kuenzi; Karen A. Maubach; N. Nagano; Guy R. Seabrook


Archive | 2010

mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1

Stephen M. Fitzjohn; Frederick M. Kuenzi; Robin A. Morton; Thomas W. Rosahl; Huw D. Lewis; David W Smith; Guy R. Seabrook; Graham L. Collingridge

Collaboration


Dive into the Frederick M. Kuenzi's collaboration.

Researchain Logo
Decentralizing Knowledge